Hip device earns breakthrough designation

JointMedica’s Polymotion hip resurfacing system received the FDA’s breakthrough device designation.

Advertisement

The Polymotion system has the biomechanical benefits of hip resurfacing without metal-on-metal articulating surfaces, according to a May 17 news release. Breakthrough designation is for products that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions; application to the program is voluntary.

Polymotion will complement Exactech’s Alteon hip arthroplasty portfolio. Exactech is a minority shareholder of JointMedica.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.